# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-20-124620
Filing Date
2020-04-29
Accepted
2020-04-29 08:33:49
Documents
36
Period of Report
2020-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.01: Changes in Control of Registrant
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d894305d8k.htm | 8-K | 50662
2 | EX-2.1 | d894305dex21.htm | EX-2.1 | 886169
3 | EX-99.1 | d894305dex991.htm | EX-99.1 | 26728
4 | EX-99.2 | d894305dex992.htm | EX-99.2 | 36729
5 | GRAPHIC | g894305ex99_2s10g1.jpg | GRAPHIC | 307898
6 | GRAPHIC | g894305ex99_2s11g1.jpg | GRAPHIC | 329102
7 | GRAPHIC | g894305ex99_2s12g1.jpg | GRAPHIC | 330674
8 | GRAPHIC | g894305ex99_2s13g1.jpg | GRAPHIC | 336905
9 | GRAPHIC | g894305ex99_2s14g1.jpg | GRAPHIC | 336629
10 | GRAPHIC | g894305ex99_2s15g1.jpg | GRAPHIC | 290539
11 | GRAPHIC | g894305ex99_2s16g1.jpg | GRAPHIC | 302407
12 | GRAPHIC | g894305ex99_2s17g1.jpg | GRAPHIC | 366171
13 | GRAPHIC | g894305ex99_2s18g1.jpg | GRAPHIC | 320598
14 | GRAPHIC | g894305ex99_2s19g1.jpg | GRAPHIC | 341365
15 | GRAPHIC | g894305ex99_2s1g1.jpg | GRAPHIC | 413833
16 | GRAPHIC | g894305ex99_2s20g1.jpg | GRAPHIC | 277831
17 | GRAPHIC | g894305ex99_2s21g1.jpg | GRAPHIC | 265297
18 | GRAPHIC | g894305ex99_2s22g1.jpg | GRAPHIC | 203308
19 | GRAPHIC | g894305ex99_2s23g1.jpg | GRAPHIC | 304603
20 | GRAPHIC | g894305ex99_2s24g1.jpg | GRAPHIC | 406193
21 | GRAPHIC | g894305ex99_2s25g1.jpg | GRAPHIC | 422073
22 | GRAPHIC | g894305ex99_2s26g1.jpg | GRAPHIC | 324107
23 | GRAPHIC | g894305ex99_2s27g1.jpg | GRAPHIC | 245065
24 | GRAPHIC | g894305ex99_2s28g1.jpg | GRAPHIC | 306438
25 | GRAPHIC | g894305ex99_2s29g1.jpg | GRAPHIC | 328324
26 | GRAPHIC | g894305ex99_2s2g1.jpg | GRAPHIC | 936468
27 | GRAPHIC | g894305ex99_2s30g1.jpg | GRAPHIC | 337383
28 | GRAPHIC | g894305ex99_2s31g1.jpg | GRAPHIC | 320708
29 | GRAPHIC | g894305ex99_2s32g1.jpg | GRAPHIC | 387224
30 | GRAPHIC | g894305ex99_2s3g1.jpg | GRAPHIC | 703050
31 | GRAPHIC | g894305ex99_2s4g1.jpg | GRAPHIC | 337203
32 | GRAPHIC | g894305ex99_2s5g1.jpg | GRAPHIC | 295741
33 | GRAPHIC | g894305ex99_2s6g1.jpg | GRAPHIC | 303440
34 | GRAPHIC | g894305ex99_2s7g1.jpg | GRAPHIC | 259437
35 | GRAPHIC | g894305ex99_2s8g1.jpg | GRAPHIC | 316622
36 | GRAPHIC | g894305ex99_2s9g1.jpg | GRAPHIC | 229168
| Complete submission text file | 0001193125-20-124620.txt |  | 16411854

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 20827563
SIC: 2834 Pharmaceutical Preparations